Catalyst Funds Management Pty »

Myriad Genetics shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $153k 34k 4.50
2024-06-30 $78k 3.2k 24.46

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Myriad Genetics

OrbiMed Advisors
BlackRock
Vanguard Group
Millennium Management
State Street Corporation
Glenview Captal Management
D. E. Shaw & Co
Vanguard Capital Management
Morgan Stanley
Vanguard Portfolio Management
Goldman Sachs Group
Geode Capital Management
Acadian Asset Management
Jacobs Levy Equity Management
Federated Investors

View all funds holding Myriad Genetics